title: Role of leukocyte plugging and edema in skeletal muscle ischemia-reperfusion injury.
abstract: The purpose of this study was to examine the relationship of increased capillary network resistance due to leukocyte-capillary plugging and tissue edema through macromolecular leakage to tissue injury after ischemia-reperfusion (I/R). After a 3-h complete ischemia in the dorsal skinfold chamber of the awake Syrian hamster, the following parameters were measured: vessel diameter, macromolecular leakage, erythrocyte velocity, adherent leukocytes, rolling leukocytes, freely flowing leukocytes, functional capillary density (FCD), propidium iodide (PI)-positive cell nuclei, and increase in network flow resistance due to leukocyte-capillary plugging. These measurements were made under baseline conditions and after 0.5 and 2 h of reperfusion for I/R alone, I/R with phalloidin (PL) treatment (to block leakage), and I/R with both PL and cytochalasin D (CD) (to block both leakage and plugging). Neither treatment had an effect on the leukocyte adherence or rolling. PL treatment preserved the endothelial barrier, improved FCD, and reduced the amount of PI measured tissue damage. CD treatment eliminated the increase in network resistance due to leukocyte plugging but did not improve FCD or tissue damage. Thus, in this I/R model, macromolecular leakage plays a role in tissue injury, whereas leukocyte plugging does not appear to be an important mechanism.
authors.affiliation: Institute for Surgical Research, University of Munich, Germany.
authors.forename: A G
authors.initials: AG
authors.lastname: Harris
authors.forename: M
authors.initials: M
authors.lastname: Steinbauer
authors.forename: R
authors.initials: R
authors.lastname: Leiderer
authors.forename: K
authors.initials: K
authors.lastname: Messmer
mesh_terms: D000818:Animals; D002196:Capillaries / Q000473:pathology / Q000503:physiopathology; D002199:Capillary Permeability / Q000187:drug effects; D002448:Cell Adhesion / Q000187:drug effects; D006224:Cricetinae; D015638:Cytochalasin D / Q000494:pharmacology; D004487:Edema / Q000503:physiopathology*; D007511:Ischemia / Q000503:physiopathology*; D007962:Leukocytes / Q000502:physiology*; D046911:Macromolecular Substances; D008297:Male; D008647:Mesocricetus; D018482:Muscle, Skeletal / Q000098:blood supply*; D010590:Phalloidine / Q000494:pharmacology; D015427:Reperfusion Injury / Q000503:physiopathology*
chemical_list: D046911:Macromolecular Substances; D010590:Phalloidine; D015638:Cytochalasin D